<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7242884\results\search\testTrace\results.xml">
  <result pre="While there is yet to be a proven cure or" exact="treatment" post="for COVID-19, commonly referred to as the coronavirus, researchers"/>
  <result pre="likely to face even more challenges accessing and affording medical" exact="treatment" post="in developing countries, especially low-income countries with under-resourced healthcare"/>
  <result pre="face of the AIDS epidemic. While there is no approved" exact="treatment" post="for COVID-19 at present, national governments are legally entitled"/>
  <result pre="should not shy away from this policy option when a" exact="treatment" post="is available. THE TRIPS AGREEMENT AND COMPULSORY LICENSING Signed"/>
  <result pre="patent holder. Specifically, issuing a compulsory license for a pharmaceutical" exact="treatment" post="allows a government to locally manufacture or import generic"/>
  <result pre="government to locally manufacture or import generic versions of the" exact="treatment" post="without the patent holderâ€™s consent. Clause 5 of the"/>
  <result pre="has determined that the antiretroviral drug could be a possible" exact="treatment" post="for COVID-19 patients. Unlike Thailand and Brazil, Israel did"/>
  <result pre="granting the use of compulsory licenses for the prevention and" exact="treatment" post="of COVID-19. Specifically, the resolution declares that the coronavirus"/>
  <result pre="provide free or affordable access to COVID-19-related preventative, diagnostic, and" exact="treatment" post="technologies through the use of compulsory licenses [14]. Other"/>
 </snippets>
</snippetsTree>
